MPM Bioventures 2018 (B), L.P.

10% owner, Entrada Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$1.9M

Companies

Latest trade

Sep 9, 2026

Companies

Entrada Therapeutics, Inc.10% owner −$1.9M

Trades

TRDA Sold 28,837 shares at $7.13 $0.2M Sep 9

TRDA Sold 192,500 shares at $7.41 $1.4M Sep 8

TRDA Sold 38,500 shares at $7.11 $0.3M Sep 4

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.